Inventor

DONELLO JOHN E

US135 patents

⚠️ This page may combine multiple inventors who share the name “DONELLO JOHN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DONELLO JOHN E

ALLERGAN INC

Methods and compositions for alleviating pain

Nonsedating α-2 agonists

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity

Treating pain using selective antagonists of persistent sodium current

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases

Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

Sulfur derivatives as chemokine receptor modulators

Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators

2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators

4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists

Methods of preventing and reducing the severity of stress-associated conditions

Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

Compositions and methods for the treatment of ophthalmic disease

Sulfur derivatives as chemokine receptor modulators

Sulfur derivatives as chemokine receptor modulators

Nonsedating α-2 agonists

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

Sulfur derivatives as chemokine receptor modulators

Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators

1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

Treatment of inflammatory bowel disease

Treating pain using selective antagonists of persistent sodium current

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators

BEARD RICHARD L

Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity

1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist

Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity

Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators

LEBLOND BERTRAND

3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity

Compounds having analgesic and/or immunostimulant activity

DIBAS MOHAMMAD I

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions

DONELLO JOHN E

Compositions and methods for treating seizure disorders

Methods for treating cognitive disorders

ALLERGAN SALES INC

Method for treating ocular pain

CHOW KEN

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol

GIL DANIEL W

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

YUAN HAIQING

Sulfur derivatives as chemokine receptor modulators